216 related articles for article (PubMed ID: 21451111)
1. CD1d and CD1c expression in human B cells is regulated by activation and retinoic acid receptor signaling.
Allan LL; Stax AM; Zheng DJ; Chung BK; Kozak FK; Tan R; van den Elzen P
J Immunol; 2011 May; 186(9):5261-72. PubMed ID: 21451111
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid regulates CD1d gene expression at the transcriptional level in human and rodent monocytic cells.
Chen Q; Ross AC
Exp Biol Med (Maywood); 2007 Apr; 232(4):488-94. PubMed ID: 17392484
[TBL] [Abstract][Full Text] [Related]
3. A novel role of CD1c in regulating CD1d-mediated NKT cell recognition by competitive binding to Ig-like transcript 4.
Li D; Hong A; Lu Q; Gao GF; Jin B; Screaton GR; Xu XN
Int Immunol; 2012 Nov; 24(11):729-37. PubMed ID: 22888216
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD1c enhances human invariant NKT cell activation by α-GalCer.
Fox LM; Miksanek J; May NA; Scharf L; Lockridge JL; Veerapen N; Besra GS; Adams EJ; Hudson AW; Gumperz JE
Cancer Immun; 2013; 13():9. PubMed ID: 23885215
[TBL] [Abstract][Full Text] [Related]
5. TLR9-induced miR-155 and Ets-1 decrease expression of CD1d on B cells in SLE.
Liu F; Fan H; Ren D; Dong G; Hu E; Ji J; Hou Y
Eur J Immunol; 2015 Jul; 45(7):1934-45. PubMed ID: 25929465
[TBL] [Abstract][Full Text] [Related]
6. CD1-Restricted T Cells at the Crossroad of Innate and Adaptive Immunity.
Pereira CS; Macedo MF
J Immunol Res; 2016; 2016():2876275. PubMed ID: 28070524
[TBL] [Abstract][Full Text] [Related]
7. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
Galli G; Nuti S; Tavarini S; Galli-Stampino L; De Lalla C; Casorati G; Dellabona P; Abrignani S
J Exp Med; 2003 Apr; 197(8):1051-7. PubMed ID: 12695492
[TBL] [Abstract][Full Text] [Related]
8. Effects of HIV-1-induced CD1c and CD1d modulation and endogenous lipid presentation on CD1c-restricted T-cell activation.
Kelly H; Mandraju R; Coelho-dos-Reis JG; Tsuji M
BMC Immunol; 2013 Jan; 14():4. PubMed ID: 23347583
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells.
Allan LL; Hoefl K; Zheng DJ; Chung BK; Kozak FK; Tan R; van den Elzen P
Blood; 2009 Sep; 114(12):2411-6. PubMed ID: 19620401
[TBL] [Abstract][Full Text] [Related]
10. CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver.
Kenna T; O'Brien M; Hogan AE; Exley MA; Porcelli SA; Hegarty JE; O'Farrelly C; Doherty DG
Cancer Immunol Immunother; 2007 Apr; 56(4):563-72. PubMed ID: 16924493
[TBL] [Abstract][Full Text] [Related]
11. Human Invariant Natural Killer T cells possess immune-modulating functions during Aspergillus infection.
Beitzen-Heineke A; Bouzani M; Schmitt AL; Kurzai O; Hünniger K; Einsele H; Loeffler J
Med Mycol; 2016 Feb; 54(2):169-76. PubMed ID: 26483428
[TBL] [Abstract][Full Text] [Related]
12. Viral danger signals control CD1d de novo synthesis and NKT cell activation.
Raftery MJ; Winau F; Giese T; Kaufmann SH; Schaible UE; Schönrich G
Eur J Immunol; 2008 Mar; 38(3):668-79. PubMed ID: 18253929
[TBL] [Abstract][Full Text] [Related]
13. CD1 antigen presentation and infectious disease.
Dascher CC; Brenner MB
Contrib Microbiol; 2003; 10():164-82. PubMed ID: 12530326
[TBL] [Abstract][Full Text] [Related]
14. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
Lang GA; Exley MA; Lang ML
Immunology; 2006 Sep; 119(1):116-25. PubMed ID: 16792697
[TBL] [Abstract][Full Text] [Related]
15. PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells.
Szatmari I; Pap A; Rühl R; Ma JX; Illarionov PA; Besra GS; Rajnavolgyi E; Dezso B; Nagy L
J Exp Med; 2006 Oct; 203(10):2351-62. PubMed ID: 16982809
[TBL] [Abstract][Full Text] [Related]
16. CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo.
Ilyinskii PO; Wang R; Balk SP; Exley MA
J Virol; 2006 Jul; 80(14):7146-58. PubMed ID: 16809320
[TBL] [Abstract][Full Text] [Related]
17. Ascites specific inhibition of CD1d-mediated activation of natural killer T cells.
Webb TJ; Giuntoli RL; Rogers O; Schneck J; Oelke M
Clin Cancer Res; 2008 Dec; 14(23):7652-8. PubMed ID: 19047090
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8
Ghnewa YG; O'Reilly VP; Vandenberghe E; Browne PV; McElligott AM; Doherty DG
Clin Immunol; 2017 Oct; 183():91-98. PubMed ID: 28780376
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments.
Moll M; Andersson SK; Smed-Sörensen A; Sandberg JK
Blood; 2010 Sep; 116(11):1876-84. PubMed ID: 20530791
[TBL] [Abstract][Full Text] [Related]
20. ICOS-dependent stimulation of NKT cells by marginal zone B cells.
Zietara N; Łyszkiewicz M; Krueger A; Weiss S
Eur J Immunol; 2011 Nov; 41(11):3125-34. PubMed ID: 21809338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
